Comparison between the P1 arm (HDAraC consolidation) and the P2 arm (TSC consolidation) in patients with intermediate cytogenetics. (A) All randomized patients with intermediate cytogenetics (143 patients). (B) Patients with normal cytogenetics (CN-AML; 114 patients).